Pangaea Ventures

Pangaea Ventures is a Venture Capital firm that invests in early- and growth-stage companies with advanced materials innovation. It aims to make the world a better place by investing in highly innovative entrepreneurs, operating lean, capital-efficient businesses enabled by breakthroughs in advanced materials. The firm is focused on maximizing the value we deliver to our partners, investors, and portfolio companies while maintaining the highest standard of integrity. Pangaea was founded in 2000 and is based in Vancouver, Canada.

Sarah Applebaum

Partner

Matthew Cohen

Director, Technology

Chris Erickson

General Partner

Janelle Goulard

Partner, Health Investment

Andrew Haughian

General Partner

Tracy Hedberg

Director of Finance and Administration

Purnesh Seegopaul

General Partner

59 past transactions

Masterson Industries, LLC

Series A in 2015
Masterson Industries is a new venture focused on the development and production of specialty materials. We’ve built a significant Intellectual Property portfolio and recently moved into a new production facility. Our products enable new capabilities for a broad range of industries that include defense, medical devices, electronics, and telecommunications. Most recently we’ve added sales and marketing expertise in each of the targeted industries. Transition from initial concept to a complete team poised for commercial expansion is complete. Preparation for the commercialization demonstration is underway.

Hazel Technologies

Series C in 2021
Hazel Technologies, Inc. designs and manufactures packaging inserts to reduce the spoilage of fruits and vegetables. It offers packaging inserts called sachets that are placed in boxes of the produce by growers at the time of harvest, extending the shelf-life of produce by slowing aging in produce and preventing fungus or decay. The company also provides agricultural and horticultural consulting services. Hazel Technologies, Inc. was founded in 2015 and is based in Chicago, Illinois with an additional location in Salinas, California.

NewLeaf Symbiotics

Series B in 2014
NewLeaf Symbiotics develops and commercializes the bacteria found in Pink Pigmented Facultative Methylotrophs. NewLeaf Symbiotics has also filed its own related patents and is actively developing new technologies related to PPFMs. The Company is engaged in laboratory, greenhouse, and field product trials and expects to commercialize and license products beginning in 2014.

NewLeaf Symbiotics

Series C in 2017
NewLeaf Symbiotics develops and commercializes the bacteria found in Pink Pigmented Facultative Methylotrophs. NewLeaf Symbiotics has also filed its own related patents and is actively developing new technologies related to PPFMs. The Company is engaged in laboratory, greenhouse, and field product trials and expects to commercialize and license products beginning in 2014.

Airborne

Private Equity Round in 2016
Airborne International is engaged in engineering, manufacturing, and supplying high-end composites structures for industries such as aerospace, defense, marine, high-end bicycles, and formula-one cars. It offers composites structures maintenance and repair services, including inspection and damage assessment, sealing and painting, and balancing. The company was founded in 1995 and is based in The Hague, the Netherlands.

SWITCH Materials

Series B in 2010
SWITCH Materials Inc. designs smart window solutions for automotive applications for OEMs and Tier 1 suppliers. It serves lower emissions, electric vehicles, customer impact, and custom solar management applications. The company was founded in 2007 and is based in Burnaby, Canada.

Airborne

Series C in 2017
Airborne International is engaged in engineering, manufacturing, and supplying high-end composites structures for industries such as aerospace, defense, marine, high-end bicycles, and formula-one cars. It offers composites structures maintenance and repair services, including inspection and damage assessment, sealing and painting, and balancing. The company was founded in 1995 and is based in The Hague, the Netherlands.

Calysta, Inc.

Series D in 2017
Calysta Energy (www.calystaenergy.com), Menlo Park, CA., is developing a new biological gas-to-liquids™ (BioGTL™) and biological gas-to-chemicals (BioGTC™) technology using methane – an energy-rich component of natural gas – as a new sustainable biological feedstock for high value industrial chemicals and transportation fuels with cost and performance advantages over current processes. The company is a spinout of DNA2.0, the largest US-based provider of synthetic genes for industrial and academic use.

Vestaron Corporation

Series C in 2014
Vestaron Corporation develops, manufactures, and sells peptide-based biologic crop protection products. It offers Spear-T, a bioinsecticide for treatment of thrips in vegetables and ornamentals in greenhouses; Spear-Lep, a bioinsecticide for fruits, vegetables, and field crops; and Leprotec, a bioinsecticide for field use. Vestaron Corporation was formerly known as Venomix, Inc. and changed its name to Vestaron Corporation in August 2009. The company was founded in 2005 and is headquartered in Durham, North Carolina with a research and development center in Kalamazoo, Michigan.

TruTag Technologies, Inc.

Series D in 2021
TruTag Technologies, Inc. is a leading authentication and technology solution provider serving businesses and governments around the world. TruTag has the most advanced precision-fabricated, cGMP nano-porous silica manufacturing operation in the world for product authentication across a broad range of industries including pharmaceuticals, food, consumer products, and industrial & electronic parts. TruTag’s authentication platform is complemented by its’ advanced hyperspectral imaging technology, which is focused on providing powerful next-generation inline quality assurance solutions and diagnostics. TruTag Technologies has been recognized by the SPIE Prism Awards, the Edison Awards, Fast Company, R&D 100, and was selected a Technology Pioneer by the World Economic Forum as one of the most influential technology companies in the world.

CarbonCure Technologies Inc.

Corporate Round in 2018
CarbonCure Technologies Inc. provides technology to existing concrete plants that allows producers to sequester carbon dioxide into their concrete products. Its technology recycles waste carbon dioxide (CO2) to make concrete products. The company source waste CO2 from industrial emitters, and is added to the concrete during production, where it is chemically converted into a limestone-like mineral. The company was formerly known as Carbon Sense Solutions Inc. and changed its name to CarbonCure Technologies Inc. in January 2011. The company was incorporated in 2007 and is based in Dartmouth, Canada.

Envia Systems

Series C in 2011
Envia Systems is a technology leader in high performance, low cost energy storage solutions using lithium ion batteries. Their disruptive products will enable widespread adoption of clean energy applications such as electric vehicles, hybrid electric vehicles, and plug-in hybrid electric vehicles.

Vestaron Corporation

Series C in 2014
Vestaron Corporation develops, manufactures, and sells peptide-based biologic crop protection products. It offers Spear-T, a bioinsecticide for treatment of thrips in vegetables and ornamentals in greenhouses; Spear-Lep, a bioinsecticide for fruits, vegetables, and field crops; and Leprotec, a bioinsecticide for field use. Vestaron Corporation was formerly known as Venomix, Inc. and changed its name to Vestaron Corporation in August 2009. The company was founded in 2005 and is headquartered in Durham, North Carolina with a research and development center in Kalamazoo, Michigan.

Calysta, Inc.

Series A in 2013
Calysta Energy (www.calystaenergy.com), Menlo Park, CA., is developing a new biological gas-to-liquids™ (BioGTL™) and biological gas-to-chemicals (BioGTC™) technology using methane – an energy-rich component of natural gas – as a new sustainable biological feedstock for high value industrial chemicals and transportation fuels with cost and performance advantages over current processes. The company is a spinout of DNA2.0, the largest US-based provider of synthetic genes for industrial and academic use.

Tactus Technology, Inc

Venture Round in 2018
Tactus Technology, Inc. designs, develops, and manufactures polymer based user interfaces for mobile devices and consumer electronic devices. It offers TrueWrite, a writing and protection film for touchscreen devices. Tactus Technology, Inc. was founded in 2008 and is based in Fremont, California with an additional office in Tokyo, Japan.

ESS, Inc.

Series C in 2019
Since their founding in 2011, ESS has been focused on laying the groundwork for a future powered by clean and reliable energy. With a team that boasts decades of experience in distributed power generation and energy storage technologies, ESS has developed an extremely cost-effective energy management system that combines a safe, abundant and non-toxic iron electrolyte with their patented flow cell design. This combination of high performance with low cost means that ESS’s technology is ideally suited for applications that range in size from retail energy management to utility-scale renewables integration.

Kovio

Venture Round in 2012
Kovio Inc., a privately held Silicon Valley company, is developing a new category of semiconductor products using printed silicon electronics and thin film technology. This new manufacturing technology combines the low cost of graphics printing with the power and functionality of silicon-based semiconductors. The company was founded in the MIT Media Laboratory.

Vestaron Corporation

Series D in 2016
Vestaron Corporation develops, manufactures, and sells peptide-based biologic crop protection products. It offers Spear-T, a bioinsecticide for treatment of thrips in vegetables and ornamentals in greenhouses; Spear-Lep, a bioinsecticide for fruits, vegetables, and field crops; and Leprotec, a bioinsecticide for field use. Vestaron Corporation was formerly known as Venomix, Inc. and changed its name to Vestaron Corporation in August 2009. The company was founded in 2005 and is headquartered in Durham, North Carolina with a research and development center in Kalamazoo, Michigan.

Vestaron Corporation

Series B in 2019
Vestaron Corporation develops, manufactures, and sells peptide-based biologic crop protection products. It offers Spear-T, a bioinsecticide for treatment of thrips in vegetables and ornamentals in greenhouses; Spear-Lep, a bioinsecticide for fruits, vegetables, and field crops; and Leprotec, a bioinsecticide for field use. Vestaron Corporation was formerly known as Venomix, Inc. and changed its name to Vestaron Corporation in August 2009. The company was founded in 2005 and is headquartered in Durham, North Carolina with a research and development center in Kalamazoo, Michigan.

ACME Advanced Materials

Seed Round in 2015
ACME Advanced Materials is a strategic technology company that establishes to commercializes a unique new form of Silicon Carbide for electronic components. Its grade devices have improved electronic transport, lower on-resistance, reduced forward voltage, and increased reliability. The company was founded in 2013 is based in Albuquerque, New Mexico.

Kovio

Venture Round in 2011
Kovio Inc., a privately held Silicon Valley company, is developing a new category of semiconductor products using printed silicon electronics and thin film technology. This new manufacturing technology combines the low cost of graphics printing with the power and functionality of silicon-based semiconductors. The company was founded in the MIT Media Laboratory.

Nanox

Series B in 2003
Nanox, Inc. develops and manufactures nanostructured perovskite-based catalyst formulations for emission control.

RSI (Reel Solar Inc)

Seed Round in 2013
RSI provides technology, tools, materials and know-how to the leaders in photovoltaic manufacturing. The company has developed a proprietary process for Rapid Efficient Electroplating on Large-areas (REEL). RSI works with regional manufacturing partners to deliver the lowest cost locally manufactured photovoltaic modules. The company was founded in 2009 by a team of capital equipment veterans based in Silicon Valley, California. Co-investors include CalCEF Angel Fund, CMEA, Mayfield Fund, Nth Power, and Pangaea Ventures.

ESS, Inc.

Series B in 2017
Since their founding in 2011, ESS has been focused on laying the groundwork for a future powered by clean and reliable energy. With a team that boasts decades of experience in distributed power generation and energy storage technologies, ESS has developed an extremely cost-effective energy management system that combines a safe, abundant and non-toxic iron electrolyte with their patented flow cell design. This combination of high performance with low cost means that ESS’s technology is ideally suited for applications that range in size from retail energy management to utility-scale renewables integration.

ESS, Inc.

Series A in 2015
Since their founding in 2011, ESS has been focused on laying the groundwork for a future powered by clean and reliable energy. With a team that boasts decades of experience in distributed power generation and energy storage technologies, ESS has developed an extremely cost-effective energy management system that combines a safe, abundant and non-toxic iron electrolyte with their patented flow cell design. This combination of high performance with low cost means that ESS’s technology is ideally suited for applications that range in size from retail energy management to utility-scale renewables integration.

Calysta, Inc.

Series C in 2016
Calysta Energy (www.calystaenergy.com), Menlo Park, CA., is developing a new biological gas-to-liquids™ (BioGTL™) and biological gas-to-chemicals (BioGTC™) technology using methane – an energy-rich component of natural gas – as a new sustainable biological feedstock for high value industrial chemicals and transportation fuels with cost and performance advantages over current processes. The company is a spinout of DNA2.0, the largest US-based provider of synthetic genes for industrial and academic use.

Correlia Biosystems, Inc.

Venture Round in 2017
Correlia Biosystems, Inc. develops microarray technology that integrates platforms for research and diagnostic applications. It offers protein detection service by analyzing micro-samples of blood. The company's technology provides multiplexing for large protein panels, which includes cytokines and post-translational modifications with unparalleled speed and automation, enables healthcare providers to quantify proteins for proteomic and pharmaceutical applications, and also allows doctors to make immediate and informed treatment decisions. Correlia Biosystems, Inc. was founded in 2013 and is based in Berkeley, California.

Tivra

Convertible Note in 2015
Tivra Corporation operates in the electronics market focussing on microelectronics, semiconductor, and LED products. The company was incorporated in 2012 and is based in Pleasant Hill, California.

Tivra

Seed Round in 2016
Tivra Corporation operates in the electronics market focussing on microelectronics, semiconductor, and LED products. The company was incorporated in 2012 and is based in Pleasant Hill, California.

Tivra

Seed Round in 2012
Tivra Corporation operates in the electronics market focussing on microelectronics, semiconductor, and LED products. The company was incorporated in 2012 and is based in Pleasant Hill, California.

Semprus BioSciences

Series B in 2010
Semprus BioSciences is a venture-backed biomedical company headquartered in Cambridge, Massachusetts. Our innovative, multi-faceted Semprus technology signifies a breakthrough in medical device technology. Our current focus is to develop a vascular access catheter with the first single surface modification that is designed to simultaneously reduce microbial adherence and thrombus accumulation over the life of the device. In December 2010, the company completed an $18 million Series B financing co-led by SR One, the corporate venture capital arm of GlaxoSmithKline, and Foundation Medical Partners (FMP), a national healthcare venture capital investment firm with a strategic relationship with Cleveland Clinic. Combined with previous financing rounds, Semprus has raised a total of $28.5 million in equity.

Semprus BioSciences

Series A in 2008
Semprus BioSciences is a venture-backed biomedical company headquartered in Cambridge, Massachusetts. Our innovative, multi-faceted Semprus technology signifies a breakthrough in medical device technology. Our current focus is to develop a vascular access catheter with the first single surface modification that is designed to simultaneously reduce microbial adherence and thrombus accumulation over the life of the device. In December 2010, the company completed an $18 million Series B financing co-led by SR One, the corporate venture capital arm of GlaxoSmithKline, and Foundation Medical Partners (FMP), a national healthcare venture capital investment firm with a strategic relationship with Cleveland Clinic. Combined with previous financing rounds, Semprus has raised a total of $28.5 million in equity.

Cnano Technology

Series A in 2007
Jiangsu Cnano Technology Co., Ltd. engages in the research and development, production, and sale of carbon nanotube materials and related products. Its products include carbon nanotube powder, carbon nanotube conductive paste, graphene composite conductive paste, carbon nanotube conductive masterbatch, and others. The company offers its products for the energy storage, structural, and electronics industries, primarily lithium-ion battery, conductive plastic, and anti-static paint. JiangSu Cnano Technology Co., Ltd. was founded in 2011 and is based in Zhenjiang, China.

Aspect Biosystems Ltd.

Venture Round in 2017
Aspect Biosystems Ltd., a biotechnology company, engages in 3D bioprinting and tissue engineering. The company offers engineering physiologically relevant 3D living tissues through its 3D bioprinting platform technology; provides Lab-on-a-printer technology that enables control over biomaterial composition and structure during tissue fabrication; and offers contract testing services on 3DAirwayALI human tissue model. Its customers include pharmaceutical firms and academics engaged in defining pathways in respiratory diseases. The company was founded in 2013 and is based in Vancouver, Canada.

Hazel Technologies

Series B in 2019
Hazel Technologies, Inc. designs and manufactures packaging inserts to reduce the spoilage of fruits and vegetables. It offers packaging inserts called sachets that are placed in boxes of the produce by growers at the time of harvest, extending the shelf-life of produce by slowing aging in produce and preventing fungus or decay. The company also provides agricultural and horticultural consulting services. Hazel Technologies, Inc. was founded in 2015 and is based in Chicago, Illinois with an additional location in Salinas, California.

Cyrium Technologies

Series B in 2005
Cyrium Technologies Inc. develops and design concentrator photovoltaic cell. The company develops, manufactures, and supplies CPV cells for terrestrial solar energy markets and CPV system manufacturers; quantum dot enhanced cells; and application-specific concentrator cells (ASCC). It also provides cell performance optimization and customization services through the ASCC program. The company was founded in 2002 and is headquartered in Ottawa, Canada with an additional office in Tsuen Wan, Hong Kong.

Inmat

Venture Round in 2003
InMat, Inc. develops, manufactures, and markets nanocomposite coating solutions. It offers Air D-Fense 2000 and Air D-Fense 3000, an aqueous suspension of nano-dispersed silicates and butyl rubber; Nanolok NP, an aqueous suspension of nano-dispersed silicates and neoprene; and Nanolok PT, an aqueous suspension of nano-dispersed silicate and polyester resin. The company’s products are used as a barrier coating, as well as applied to various elastomeric substrates through spray or dip coating processes. It serves packaging, automotive, medical, protective apparel, and sports equipment markets. InMat, Inc. was founded in 1999 and is headquartered in Hillsborough, New Jersey.

Redlen Technologies

Series A in 2015
Redlen Technologies is a leading manufacturer of high resolution Cadmium Zinc Telluride (CZT) semiconductor radiation detectors which are enabling a new generation of high performance detection and imaging equipment including Nuclear Cardiology, CT Scanning, Baggage Scanning and Dirty Bomb Detection. Having successfully pioneered a breakthrough production process for manufacturing advanced CZT semiconductor wafers with its proprietary Traveling Heater Method (THM) technology, Redlen is revolutionizing the performance, cost and availability of radiation detection and imaging – enabling the widespread adoption of this technology for the medical and security markets. The company also offers an advanced thin film solar Cadmium Telluride (CdTe) feedstock product, delivering volume quantities of high purity, high performance semiconductor material to the Thin Film Solar Photovoltaic (PV) market. With its industry-leading CZT growth technology, pioneered by a management and technical team that is deeply rooted in semiconductor and imaging technology, Redlen is changing the landscape for high performance, cost effective radiation-based medical and security imaging equipment.

Boulder Ionics

Series A in 2012
Boulder Ionics is a rapidly growing start-up that produces ionic liquids and ionic liquid based electrolytes for demanding electrochemical applications. Using a proprietary high-throughput synthesis platform, Boulder Ionics is able to manufacture ultra-high-purity ionic liquids at a superior price/performance ratio. Boulder Ionics’ advanced Iolyte™ electrolytes and pure ionic liquids have applications in a wide range of products ranging from ultracapacitors to lithium-ion batteries and next generation metal-air batteries. The company is currently working with several strategic partners and industry leaders and expects full integration of Iolyte™ electrolytes into a growing number of commercial products by mid-2012.

Aspect Biosystems Ltd.

Series A in 2020
Aspect Biosystems Ltd., a biotechnology company, engages in 3D bioprinting and tissue engineering. The company offers engineering physiologically relevant 3D living tissues through its 3D bioprinting platform technology; provides Lab-on-a-printer technology that enables control over biomaterial composition and structure during tissue fabrication; and offers contract testing services on 3DAirwayALI human tissue model. Its customers include pharmaceutical firms and academics engaged in defining pathways in respiratory diseases. The company was founded in 2013 and is based in Vancouver, Canada.

Kovio

Series E in 2009
Kovio Inc., a privately held Silicon Valley company, is developing a new category of semiconductor products using printed silicon electronics and thin film technology. This new manufacturing technology combines the low cost of graphics printing with the power and functionality of silicon-based semiconductors. The company was founded in the MIT Media Laboratory.

Modulated Imaging

Series B in 2019
Modulim is a leader in a breakthrough technology in tissue and vascular assessment,called, spatial frequency domain imaging or SFDI. Powered by SFDI, our Clarifi Imaging System helps identify patients at risk of complications such as diabetic foot ulcers and amputations due to potential compromised circulation so clinicians can provide more timely intervention and save patients' limbs and lives.

Masterson Industries, LLC

Series A in 2013
Masterson Industries is a new venture focused on the development and production of specialty materials. We’ve built a significant Intellectual Property portfolio and recently moved into a new production facility. Our products enable new capabilities for a broad range of industries that include defense, medical devices, electronics, and telecommunications. Most recently we’ve added sales and marketing expertise in each of the targeted industries. Transition from initial concept to a complete team poised for commercial expansion is complete. Preparation for the commercialization demonstration is underway.

Redlen Technologies

Venture Round in 2014
Redlen Technologies is a leading manufacturer of high resolution Cadmium Zinc Telluride (CZT) semiconductor radiation detectors which are enabling a new generation of high performance detection and imaging equipment including Nuclear Cardiology, CT Scanning, Baggage Scanning and Dirty Bomb Detection. Having successfully pioneered a breakthrough production process for manufacturing advanced CZT semiconductor wafers with its proprietary Traveling Heater Method (THM) technology, Redlen is revolutionizing the performance, cost and availability of radiation detection and imaging – enabling the widespread adoption of this technology for the medical and security markets. The company also offers an advanced thin film solar Cadmium Telluride (CdTe) feedstock product, delivering volume quantities of high purity, high performance semiconductor material to the Thin Film Solar Photovoltaic (PV) market. With its industry-leading CZT growth technology, pioneered by a management and technical team that is deeply rooted in semiconductor and imaging technology, Redlen is changing the landscape for high performance, cost effective radiation-based medical and security imaging equipment.
CarbonCure Technologies Inc. provides technology to existing concrete plants that allows producers to sequester carbon dioxide into their concrete products. Its technology recycles waste carbon dioxide (CO2) to make concrete products. The company source waste CO2 from industrial emitters, and is added to the concrete during production, where it is chemically converted into a limestone-like mineral. The company was formerly known as Carbon Sense Solutions Inc. and changed its name to CarbonCure Technologies Inc. in January 2011. The company was incorporated in 2007 and is based in Dartmouth, Canada.

SWITCH Materials

Series C in 2015
SWITCH Materials Inc. designs smart window solutions for automotive applications for OEMs and Tier 1 suppliers. It serves lower emissions, electric vehicles, customer impact, and custom solar management applications. The company was founded in 2007 and is based in Burnaby, Canada.

Calysta, Inc.

Series B in 2015
Calysta Energy (www.calystaenergy.com), Menlo Park, CA., is developing a new biological gas-to-liquids™ (BioGTL™) and biological gas-to-chemicals (BioGTC™) technology using methane – an energy-rich component of natural gas – as a new sustainable biological feedstock for high value industrial chemicals and transportation fuels with cost and performance advantages over current processes. The company is a spinout of DNA2.0, the largest US-based provider of synthetic genes for industrial and academic use.

Cnano Technology

Series B in 2015
Jiangsu Cnano Technology Co., Ltd. engages in the research and development, production, and sale of carbon nanotube materials and related products. Its products include carbon nanotube powder, carbon nanotube conductive paste, graphene composite conductive paste, carbon nanotube conductive masterbatch, and others. The company offers its products for the energy storage, structural, and electronics industries, primarily lithium-ion battery, conductive plastic, and anti-static paint. JiangSu Cnano Technology Co., Ltd. was founded in 2011 and is based in Zhenjiang, China.

NewLeaf Symbiotics

Series A in 2013
NewLeaf Symbiotics develops and commercializes the bacteria found in Pink Pigmented Facultative Methylotrophs. NewLeaf Symbiotics has also filed its own related patents and is actively developing new technologies related to PPFMs. The Company is engaged in laboratory, greenhouse, and field product trials and expects to commercialize and license products beginning in 2014.

TruTag Technologies, Inc.

Series C in 2019
TruTag Technologies, Inc. is a leading authentication and technology solution provider serving businesses and governments around the world. TruTag has the most advanced precision-fabricated, cGMP nano-porous silica manufacturing operation in the world for product authentication across a broad range of industries including pharmaceuticals, food, consumer products, and industrial & electronic parts. TruTag’s authentication platform is complemented by its’ advanced hyperspectral imaging technology, which is focused on providing powerful next-generation inline quality assurance solutions and diagnostics. TruTag Technologies has been recognized by the SPIE Prism Awards, the Edison Awards, Fast Company, R&D 100, and was selected a Technology Pioneer by the World Economic Forum as one of the most influential technology companies in the world.

Cyrium Technologies

Series B in 2008
Cyrium Technologies Inc. develops and design concentrator photovoltaic cell. The company develops, manufactures, and supplies CPV cells for terrestrial solar energy markets and CPV system manufacturers; quantum dot enhanced cells; and application-specific concentrator cells (ASCC). It also provides cell performance optimization and customization services through the ASCC program. The company was founded in 2002 and is headquartered in Ottawa, Canada with an additional office in Tsuen Wan, Hong Kong.

Sun Genomics

Series A in 2020
Sun Genomics is a microbiome health company focused on curing dysbiosis through personalized probiotics. its flagship product Floré, a microbiome test and gut probiotics solution that utilizes whole-genome sequencing to evaluate different digestive system data points and ensure that customers receive a completely personalized product that is based on their unique gut profiles. The company also offers Floré Tots, which is available for kids up to age 12 and comes in an easy digestive powder to mix with their favorite drink.

SWITCH Materials

Venture Round in 2007
SWITCH Materials Inc. designs smart window solutions for automotive applications for OEMs and Tier 1 suppliers. It serves lower emissions, electric vehicles, customer impact, and custom solar management applications. The company was founded in 2007 and is based in Burnaby, Canada.

Vestaron Corporation

Series B in 2012
Vestaron Corporation develops, manufactures, and sells peptide-based biologic crop protection products. It offers Spear-T, a bioinsecticide for treatment of thrips in vegetables and ornamentals in greenhouses; Spear-Lep, a bioinsecticide for fruits, vegetables, and field crops; and Leprotec, a bioinsecticide for field use. Vestaron Corporation was formerly known as Venomix, Inc. and changed its name to Vestaron Corporation in August 2009. The company was founded in 2005 and is headquartered in Durham, North Carolina with a research and development center in Kalamazoo, Michigan.

AEPONYX

Series A in 2019
AEPONYX INC. designs and manufactures fabless micro optical switch semiconductor chips for tunable transceivers and optical circuit switches. The company uses micro-electro-mechanical-systems and silicon photonics for use in disaggregated switching systems and enabling tunability in both transmission and reception in pluggable transceivers. The company was founded in 2011 and is based in Montreal, Canada.

polySpectra

Venture Round in 2017
PolySpectra transforms 3D printing from a prototyping aid into a production manufacturing tool. PolySpectra makes functional materials for advanced additive manufacturing. The company uses light-activated catalysts to 3D print advanced functional materials. Its modular platform enables us to deliver materials with a broad spectrum of tailored properties from a single chemical system. PolySpectra helps inventors, designers, and engineers make their ideas real. Founded in 2016 by Raymond Weitekamp, PolySpectra is headquartered in Berkeley, California.

Redlen Technologies

Series B in 2017
Redlen Technologies is a leading manufacturer of high resolution Cadmium Zinc Telluride (CZT) semiconductor radiation detectors which are enabling a new generation of high performance detection and imaging equipment including Nuclear Cardiology, CT Scanning, Baggage Scanning and Dirty Bomb Detection. Having successfully pioneered a breakthrough production process for manufacturing advanced CZT semiconductor wafers with its proprietary Traveling Heater Method (THM) technology, Redlen is revolutionizing the performance, cost and availability of radiation detection and imaging – enabling the widespread adoption of this technology for the medical and security markets. The company also offers an advanced thin film solar Cadmium Telluride (CdTe) feedstock product, delivering volume quantities of high purity, high performance semiconductor material to the Thin Film Solar Photovoltaic (PV) market. With its industry-leading CZT growth technology, pioneered by a management and technical team that is deeply rooted in semiconductor and imaging technology, Redlen is changing the landscape for high performance, cost effective radiation-based medical and security imaging equipment.

Pionetics Corporation

Series C in 2005
Pionetics Corporation manufactures water treatment products that produce drinking water. It offers water filters and drinking water systems, and water coolers. The company also provides installation services and its drinking water systems on rent. Its products are used for household, commercial, and industrial applications. The company offers its products through authorized dealers in the United States and internationally. The company was founded in 1995 and is headquartered in San Carlos, California. As of 2008, Pionetics Corporation operates as a subsidiary of Rayne Corporation.
CarbonCure Technologies Inc. provides technology to existing concrete plants that allows producers to sequester carbon dioxide into their concrete products. Its technology recycles waste carbon dioxide (CO2) to make concrete products. The company source waste CO2 from industrial emitters, and is added to the concrete during production, where it is chemically converted into a limestone-like mineral. The company was formerly known as Carbon Sense Solutions Inc. and changed its name to CarbonCure Technologies Inc. in January 2011. The company was incorporated in 2007 and is based in Dartmouth, Canada.